BioSpace News Archive

Drug Development

Epizyme Announces Conference Call to Discuss Phase 2 Tazemetostat Follicular Lymphoma Data

Epizyme, Inc. announced that management will host a conference call on Friday, June 21, 2019 at 8:30 a.m. ET to discuss updated data from an ongoing Phase 2 study of its lead candidate, tazemetostat, as a monotherapy for patients with relapsed or refractory follicular lymphoma.

June 12, 2019
·
4 min read
Business

Synlogic and Ginkgo Bioworks Establish Transformational Platform Collaboration for the Accelerated Development of Novel Synthetic Biotic™ Medicines

Fuels development of Synlogic’s growing pipeline of novel living medicines with technology access and $80.0 million equity investment at a premium

June 12, 2019
·
6 min read
Deals

Lannett To Participate At Two Investor Conferences In June

Lannett Company, Inc. announced its participation at two upcoming investor conferences.

June 12, 2019
·
1 min read
Drug Development

Alkermes Advances ALKS 4230 into Monotherapy Expansion Phase of ARTISTRY-1 in Patients With Renal Cell Carcinoma or Melanoma

Alkermes plc announced the initiation of the monotherapy expansion stage of its ARTISTRY-1 clinical trial to evaluate the efficacy, safety and tolerability of ALKS 4230 in treating patients with renal cell carcinoma or melanoma.

June 12, 2019
·
7 min read
Drug Development

Concert Pharmaceuticals Reports Positive Results from Phase 1 Studies Evaluating CTP-692 in Healthy Volunteers

The Company Expects to Initiate a Phase 2 Trial in Patients with Schizophrenia in the Fourth Quarter of 2019

June 12, 2019
·
7 min read
Business

YourDNA and Cure Rare Disease Announce Partnership to Increase Awareness for Duchenne Muscular Dystrophy (and More)

CureRareDisease.org brings together researchers and clinicians to develop customized therapeutics applied to Duchenne Muscular Dystrophy and other rare diseases

June 12, 2019
·
3 min read
Business

Cirius Therapeutics Expands Scientific Advisory Board

Cirius Therapeutics announced that Daniel Bloomfield M.D., will be joining Cirius’ scientific advisory board.

June 12, 2019
·
2 min read
FDA

Bolder BioTechnology Announces FDA Orphan Drug Designation for BBT-059 for Acute Radiation Syndrome

Orphan drug designation provides seven years of market exclusivity for the drug, tax incentives for clinical trial development, waiver of Biologics License Application fees, and a closer working relationship with the Food and Drug Administration.

June 12, 2019
·
2 min read
Business

Hyundai Hope On Wheels Presents Orlando Health Arnold Palmer Hospital For Children With $100,000 Hyundai Impact Award Grant To Support Pediatric Cancer Research

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this Summer to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research

June 12, 2019
·
4 min read
Biotech Beach

Medical Marijuana, Inc. Announces Completion of the First-Ever High-Level Stability Study on a CBD Hemp Oil Product

The stability study was conducted in strict compliance with FDA/ICH guidelines (Q1A-R2).

June 12, 2019
·
5 min read